1Savelleva I, Camm J. Update on atrial fibrillation: part Ⅰ[J]. Clin Cardiol, 2008, 31(2):55-62.
2Takahashi N, Seki A, Imataka K, et al.Clinical features of paroxysmal atrial fibrillation: an observation of 94 patients[J]. Jpn Heart J, 1981,22(2):143-149.
3Kannel WB, Abbott RD, Savage DD, et al. Coronary heart disease and atrial fibrillation: the Framingham Study[J]. Am Heart J,1983,106(2):389-396.
4Peterson P, Godtfredsen J.Embolic complications in paroxysmal atrial fibrillation[J].Stroke, 1986,17(4):622-626.
5Suttorp MJ, Kingma JH, Koomen EM, et al. Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function[J].Am J Cardiol, 1993,71(8):710-713.
6Kopecky SL, Gersh BJ, McGoon MD, et al.The natural history of lone atrial fibrillation. A population-based study over three decades[J]. N Engl J Med, 1987,317(11):669-674.
7Dilaveris PE, Gialafos EJ, Sideris SK, et al. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation[J]. Am Heart J, 1998,135(5 Pt 1):733-738.
8Abe Y, Fukunami M, Yamada T, et al. Prediction of transition to chronic atrial fibrillation in patients with paroxysmal atrial fibrillation by signal-averaged electrocardiography[J]. Circulation, 1997,96(8):2612-2616.
9Saksena S, Slee A, Waldo AL, et al. Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analyses[J]. J Am Coll Cardiol, 2011,58(19):1975-1985.
